Recent 2025 guidance from the Association of Anaesthetists and MAGIC‑ONC marks an important shift in how vascular access is approached in adult cancer care. Rather than introducing new devices or techniques, the emphasis is on improving how and when decisions are made, with the aim of reducing variation and preventable harm.
As treatments become more complex and patient pathways more prolonged, vascular access is increasingly recognised as a strategic clinical choice rather than a purely technical procedure.
What Has Changed?
The guidance highlights that complications such as infection, thrombosis and venous depletion are often linked to inappropriate or poorly timed device selection. By analysing over 1,400 real‑world scenarios, MAGIC‑ONC reinforces that choosing the right device, at the right time, for the right patient can significantly influence outcomes.
Key themes emerging from the guidance include:
- The importance of aligning device choice with treatment urgency, expected dwell time and disease type
- Recognition of vascular access choice as a modifiable risk factor
- A move towards simpler, more consistent maintenance practices
- Reduced reliance on routine interventions that add risk without clear benefit
A Focus on Consistency, not Complexity
Rather than adding layers of process, the 2025 recommendations encourage standardised decision‑making supported by shared frameworks. This helps teams:
- Reduce unwarranted variation in practice
- Improve collaboration across oncology, vascular access and anaesthetic services
- Balance patient preference with clinical safety
- Support long‑term vessel preservation
Why This Matters for Services
For healthcare organisations, the guidance provides an opportunity to strengthen safety, efficiency and patient experience without increasing workload. Clearer pathways and appropriateness‑based decisions can support:
- Fewer access‑related complications
- More predictable workflows
- Improved continuity of care across treatment phases
In Conclusion
The latest vascular access guidance is less about changing what clinicians do, and more about supporting better, more confident decisions. By shifting the focus from individual devices to the overall patient journey, it creates a foundation for safer, more consistent vascular access care across services.
To read the study summary, visit our website – https://campusvygon.com/uk/vascular-access/study-summary-new-2025-guidance-on-safe-vascular-access-what-clinicians-need-to-know/
To view our Vascular Access Guidelines infographic, click here – https://campusvygon.com/uk/wp-content/uploads/sites/9/2026/05/Dos-and-donts-VA-practice-infographic-scaled.png
Bibliography
Chopra V, Swaminathan L, LeDonne J, Becker C, Krein SL, et al.
The Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC‑ONC): Results from a multispecialty panel using the RAND/UCLA Appropriateness Method.
Ann Intern Med. 2025;178(Suppl 12):S1.
Johnston AJ, Simpson MJ, McCormack V, Barton A, Bennett J, Chalisey A, et al.
Association of Anaesthetists guidelines: safe vascular access 2025.
Anaesthesia. 2025;80(11):1381–1396. doi:10.1111/anae.16727.
